Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
CXSL2300477	QL2107注射液	pembrolizumab	Injection	Biological Products(3.3)	New Drug Application	2023-07-13	QILU Pharmaceutical Co Ltd	view
CXSL2500217	QL2107注射液	pembrolizumab	Injection	Biological Products(2.2)	New Drug Application	2025-03-11	QILU Pharmaceutical Co Ltd	view
CXSL2500085	QL2107注射液	pembrolizumab	Injection	Biological Products(2.2)	New Drug Application	2025-01-27	QILU Pharmaceutical Co Ltd	view
CXSL2500028	QL2107注射液	pembrolizumab	Injection	Biological Products(2.2)	New Drug Application	2025-01-09	QILU Pharmaceutical Co Ltd	view